Clinical Trials in Reutlingen, Germany
Locations / Reutlingen, Germany
Delta Trials records 102 clinical trials conducted in Reutlingen, Germany, making it a notable site of clinical research activity. These trials across 142 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 5 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Reutlingen has changed over time.
102
Total Trials
142
Conditions
5
Terminated since 2020
Browse by condition (142 total)
- Breast cancer 8 trialsAll Breast cancer trials
- Prostate cancer 5 trialsAll Prostate cancer trials
- Urinary bladder, overactive 3 trialsAll Urinary bladder, overactive trials
- Colorectal cancer 3 trialsAll Colorectal cancer trials
- Ovarian cancer 3 trialsAll Ovarian cancer trials
- Gastric cancer 3 trialsAll Gastric cancer trials
- Urinary bladder diseases 2 trialsAll Urinary bladder diseases trials
- Atrial fibrillation 2 trialsAll Atrial fibrillation trials
- Prostate cancer metastatic 2 trialsAll Prostate cancer metastatic trials
- Colorectal neoplasms 2 trialsAll Colorectal neoplasms trials
- Hereditary tyrosinemia, type i 2 trialsAll Hereditary tyrosinemia, type i trials
- Metastatic colorectal cancer 2 trialsAll Metastatic colorectal cancer trials
- Severe chronic pain 2 trialsAll Severe chronic pain trials
- Neuromuscular blockade 2 trialsAll Neuromuscular blockade trials
- Urologic diseases 2 trialsAll Urologic diseases trials
- Rheumatoid arthritis 2 trialsAll Rheumatoid arthritis trials
- Gastroesophageal reflux disease 2 trialsAll Gastroesophageal reflux disease trials
- Multiple myeloma 2 trialsAll Multiple myeloma trials
- Her2-positive gastric cancer 2 trialsAll Her2-positive gastric cancer trials
- Anxiety disorders 1 trialAll Anxiety disorders trials